In the United States pharmaceutical market, a product launch is one of the most financially and … How Poor Branding Hurts Pharma Product LaunchesRead more
Strategy & Execution
How-tos, frameworks, omnichannel planning, and marketing roadmaps.
How Market Access Challenges Detail Pharma Growth
The United States pharmaceutical industry is one of the most advanced and competitive healthcare markets in … How Market Access Challenges Detail Pharma GrowthRead more
How AI Can Improve Clinical Trial Design and Outcomes
Clinical trials are the most expensive, time-consuming, and failure-prone phase of drug development. Despite advances in … How AI Can Improve Clinical Trial Design and OutcomesRead more
Why Pharma Sales Teams Struggle in a Digital-First World
The pharmaceutical industry has long relied on in-person interactions between sales representatives and healthcare professionals to … Why Pharma Sales Teams Struggle in a Digital-First WorldRead more
The Hidden Costs of Failed Clinical Trials
Clinical trial failure is often framed as a scientific setback – a missed endpoint, an unexpected … The Hidden Costs of Failed Clinical TrialsRead more
Why Traditional Pharma Marketing No Longer Works
The pharmaceutical industry has historically relied on a predictable playbook for bringing new therapies to market. … Why Traditional Pharma Marketing No Longer WorksRead more
How Marketing and Medical Affairs Can Work Better Together
In the modern pharmaceutical landscape, few internal relationships are as strategically important as the one between … How Marketing and Medical Affairs Can Work Better TogetherRead more
Why Clinical Trial Data Fails to Translate Into Market Success
A therapy can clear Phase III, secure FDA approval, and generate headline optimism-only to miss revenue … Why Clinical Trial Data Fails to Translate Into Market SuccessRead more
How Poor Communication Between Teams Slows Drug Development
Drug development is often framed as a scientific challenge. Breakthroughs hinge on molecular discovery, biomarker validation, … How Poor Communication Between Teams Slows Drug DevelopmentRead more
Why Regulatory Delays Are Only Part of the U.S. Clinical Trial Problem
When a development program misses projected timelines, the explanation often centers on regulatory review. FDA feedback … Why Regulatory Delays Are Only Part of the U.S. Clinical Trial ProblemRead more